Loading...
NPI 1073268322 · Sun Valley, CA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Star Medical Laboratory Inc is a clinical medical laboratory provider located in Sun Valley, California. This profile covers 49 Medicare and 42 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Star Medical Laboratory Inc |
| Address | 8588 Telfair Ave Ste B |
| City | Sun Valley |
| State | CA |
| ZIP | 91352 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | February 15, 2022 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $7M |
| Medicaid | $136.7K |
STAR MEDICAL LABORATORY’s billing profile is heavily concentrated in molecular infectious-disease testing: the top Medicare revenue drivers are 87798, 87150, and 87481, all amplified nucleic acid probe (NAAT) assays for infectious agents (92.8K, 41.4K and 30.4K claims respectively under Medicare). The same three codes dominate Medicaid billing as well, indicating the lab operates primarily as a high-volume NAAT/reference testing service rather than a routine outpatient draw site.
Revenue concentration is extreme: the precomputed top-3 Medicare codes account for 81.8% of the provider’s total Medicare revenue, and the top-3 Medicaid codes account for 78.5% of its Medicaid revenue. This concentration shows most of the provider’s financial performance depends on a narrow set of molecular diagnostic services.
The payer mix is strongly Medicare-dominant in scale: lifetime Medicare revenue is $7M compared with total Medicaid revenue of $136.7K, so Medicare payments are driving virtually all reported lifetime revenue for this NPI. Medicaid activity exists but represents a small fraction of the provider’s revenue footprint.
On Medicare this provider is a national outlier for its flagship NAAT codes: 87798 ranks #16 of 1319 providers nationally (99th percentile; extreme outlier) and 87481 ranks #12 of 1117 providers nationally (99th percentile; extreme outlier), while 87150 is also notably elevated at rank #10 of 190 providers nationally (95th percentile). Those rankings indicate the lab is operating at volumes far above typical national peers for these molecular assays.
In-state Medicaid competitive standing is strong but more typical in magnitude: 87798 ranks #34 of 395 providers in-state (92th percentile) and 87150 ranks #7 of 81 providers in-state (93th percentile), while certain other NAAT codes such as 87640 rank #4 of 95 providers in-state (97th percentile; notably above typical state volume). This pattern suggests the lab is a recognized regional player for specific molecular tests, though the extremity seen in Medicare national ranks is attenuated at the state Medicaid level.
Reimbursement and pricing differences amplify Medicare revenue: the top NAAT Medicare codes report $34 avg paid/claim on Medicare (for 87798, 87150, 87481 and others), whereas the same top codes on Medicaid show much lower avg paid/claim figures (for example 87798 at $11 avg paid/claim, 87150 at $6 avg paid/claim, and 87481 at $5 avg paid/claim). Given similar claim volumes across payers for those tests, higher Medicare rates are a primary reason Medicare accounts for the bulk of revenue.
The provider’s service mix includes some routine clinical chemistry and endocrine assays (e.g., 82306 vitamin D, 84443 TSH, 83036 A1C) but these codes contribute only small shares of Medicare revenue (individual entries at the hundreds to low‑thousands of dollars). Those lower-revenue chemistry and hormone tests indicate some broader clinical lab capability, but they are ancillary to the lab’s core high-volume molecular testing business.
STAR MEDICAL LABORATORY is a relatively recent NPI registrant (enumerated 2022-02-15, ~4 years ago) and has already scaled to high volumes on specialized NAAT codes. The combination of recent enumeration and outsized national rankings on multiple molecular codes suggests a rapid build-out focused on infectious disease molecular diagnostics rather than a long-established general clinical lab footprint.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
49 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 92,800 | $30 | $3.2M |
| 87150 | The lab analyst performs an analysis using amplified DNA or RNA probe technique on a previously isolated and identified organism to categorize the organism more specifically, such as to the taxonomic… | 41,420 | $30 | $1.4M |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 30,410 | $30 | $1M |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 7,060 | $30 | $240K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 6,960 | $30 | $236.5K |
| 87641 | The lab analyst performs a test for methicillin–resistant Staphylococcus aureus (MRSA) using an amplified nucleic acid probe technique. | 5,920 | $30 | $201.1K |
| 87500 | The lab analyst performs a test for vancomycin resistance in an infectious organism’s nucleic acid using amplified probe technique. VRE, vancomycin resistant enterococcus, is the most common organism… | 5,820 | $30 | $197.8K |
| 87486 | The lab analyst performs a test for Chlamydia pneumoniae using amplified nucleic acid probe technique. Chlamydia pneumoniae also known as TWAR, Taiwan Acute Respiratory agent, commonly causes mild… | 1,250 | $30 | $42.3K |
| 87581 | The lab analyst performs a test for Mycoplasma pneumonia, a bacteria, using amplified nucleic acid probe technique. | 1,250 | $30 | $42.3K |
| 87541 | The lab analyst performs a test for the bacteria Legionella pneumophila using amplified nucleic acid probe technique. L. pneumophila can inhabit facility water and air conditioning systems and may… | 1,240 | $30 | $42.1K |
Showing 1–10 of 49
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 49 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
49 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 87798 | 2 | 110 | 1,340 | $30 | $338.2K |
| 87150 | 2 | 30 | 1,690 | $30 | $222.6K |
| 87481 | 2 | 100 | 270 | $30 | $72.7K |
| 82306 | 50 | 490 | 100 | $30 | $44.2K |
| 86003 | 12 | 40 | 2,880 | $10 | $41.5K |
| 84443 | 65 | 620 | 120 | $20 | $39.4K |
| 87541 | 10 | 30 | 630 | $30 | $37.5K |
| 87640 | 2 | 70 | 270 | $30 | $35.7K |
| 80061 | 158 | 700 | 110 | $10 | $35.3K |
| 87486 | 11 | 40 | 430 | $30 | $31.4K |
Showing 1–10 of 49
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
42 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 6,200 | $10 | $68.2K |
| 87150 | The lab analyst performs an analysis using amplified DNA or RNA probe technique on a previously isolated and identified organism to categorize the organism more specifically, such as to the taxonomic… | 3,870 | $10 | $23.2K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 3,910 | $10 | $19.5K |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 6,200 | $1 | $6.2K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 6,100 | $1 | $6.1K |
| 87500 | The lab analyst performs a test for vancomycin resistance in an infectious organism’s nucleic acid using amplified probe technique. VRE, vancomycin resistant enterococcus, is the most common organism… | 3,790 | $1 | $3.8K |
| 87641 | The lab analyst performs a test for methicillin–resistant Staphylococcus aureus (MRSA) using an amplified nucleic acid probe technique. | 3,480 | $1 | $3.5K |
| 87651 | The lab analyst performs a test for the bacteria Streptococcus, group A, using amplified nucleic acid probe technique. Strep A commonly causes acute pharyngitis, or strep throat. | 2,450 | $1 | $2.4K |
| 87486 | The lab analyst performs a test for Chlamydia pneumoniae using amplified nucleic acid probe technique. Chlamydia pneumoniae also known as TWAR, Taiwan Acute Respiratory agent, commonly causes mild… | 2,440 | $1 | $2.4K |
| 87541 | The lab analyst performs a test for the bacteria Legionella pneumophila using amplified nucleic acid probe technique. L. pneumophila can inhabit facility water and air conditioning systems and may… | 2,430 | $1 | $2.4K |
Showing 1–10 of 42
How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. California median
42 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 1,555 | 1,720 | 1,360 | $10 | $165.3K |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 158 | 170 | 260 | $30 | $146K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 564 | 1,360 | 590 | $10 | $74.1K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 534 | 1,110 | 300 | $10 | $70.2K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 34 | 400 | 330 | $20 | $67.9K |
| 87150 | The lab analyst performs an analysis using amplified DNA or RNA probe technique on a previously isolated and identified organism to categorize the organism more specifically, such as to the taxonomic… | 7 | 80 | 200 | $30 | $62.2K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 1,500 | 1,610 | 640 | $1 | $53.5K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 25 | 210 | 420 | $10 | $42.4K |
| 84403 | The lab analyst performs a test to measure total testosterone, typically in patient serum. | 94 | 240 | 240 | $10 | $37.6K |
| 87651 | The lab analyst performs a test for the bacteria Streptococcus, group A, using amplified nucleic acid probe technique. Strep A commonly causes acute pharyngitis, or strep throat. | 49 | 320 | 590 | $20 | $29.1K |
Showing 1–10 of 42
Other providers in the same ZIP code as Star Medical Laboratory Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Northeast Valley Health Corporation | CA | Federally Qualified Health Center (FQHC) | $0 | $46.9M |
| Zinovy Lekht | CA | Neurology Physician | $1.6M | $0 |
| Sheila Manhas | CA | Neurology Physician | $1.4M | $0 |
| Vicrumdeep Tung | CA | General Practice Physician | $705.6K | $0 |
| Arman Tobakyan | CA | Occupational Therapist | $435.5K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.